Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's. The enemy of our ...

Anavex (AVXL) blarcamesine faces uncertain FDA path in early Alzheimer’s; Phase 3 may be needed. Read here a detailed ...

New insights into the causes and treatments of Alzheimer’s are offering hope for those at risk and those who are battling the ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

Conventional treatments of Alzheimer's disease, one of the most common forms of dementia, have been largely focused on ...

The State House's Hall of Flags was covered in purple Thursday morning for Alzheimer's Advocacy Day.

What began as a surprising experiment with cell phone-like signals has led to a promising new approach to treating ...

Panelists discuss how APPs facilitate efficient Alzheimer treatment timelines through proactive coordination. Panelists discuss how initiating Alzheimer therapy demands precise timing and ...

Researchers have found that a natural aging-related molecule can repair key memory processes affected by Alzheimer’s disease.

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that the ...

Inspired by changes observed during his mother’s treatment, a neurologist is testing ultrasound as a standalone therapy for Alzheimer’s, a departure from mainstream research and one still shrouded in ...

Memory dysfunction in Alzheimer's disease may be linked to impairment in how the brain replays our recent experiences while we are resting, according to a new study in mice by University College ...